RxDoctor Payments Data

Theresa Bodker

Clinical Nurse Specialist · Lafayette, LANPI 1629358866

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 46 manufacturers reported payments, led by Genentech USA, Inc. at 56.9% of the total. Reporting peaked in 2021 at $5,123 and has fallen 92.8% since, to $369 in 2025.

$6,306in general payments, 2019–2025

Across 121 payments — averaging $52.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$4K
  • Novartis$333
  • AstraZeneca$272
  • Amgen$214
  • Sanofi-aventis U.S. LLC$200
  • Eisai Inc.$171
  • plus $2K from 40 others

What the payments were for

  • Speaking & faculty fees$2,80044%
  • Travel & lodging$5539%
  • Food & beverage$2,55541%
  • Education$3996%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few clinical nurse specialist providers in Louisianato place this figure against a meaningful peer group, so we don't.

Other clinical nurse specialist in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →